Illumina, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $265.75
- 52-Week Range
- $88.00 – $280.17
- Market Cap
- $41.23B
- P/E (TTM)
- 50.94
- EPS (TTM)
- 5.36
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 14.53
- PEG Ratio
- 3.37
- Return on Equity
- 32.34%
- Return on Assets
- 8.67%
- Gross Margin
- 67.93%
- Operating Margin
- 21.14%
- Profit Margin
- 18.34%
- Current Ratio
- 1.80
- Debt/Equity
- 0.89
- Total Debt
- $2.53B
- Free Cash Flow
- $797.63M
- Revenue Growth
- 9.40%
- Earnings Growth
- -9.40%
- Enterprise Value
- $42.59B
Market Snapshot
About
Illumina, Inc. is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Illumina's sequencing and array-based solutions serve customers in research centers, academic institutions, government laboratories, and hospitals around the world. The company is a dominant player in the next-generation sequencing market and has enabled breakthroughs in genomics research and precision medicine.